Navigation Links
Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
Date:5/19/2008

MARSEILLE, France, May 19 /PRNewswire/ -- IPSOGEN SA (Marseille and New Haven), a cancer profiler that develops and markets molecular diagnostic assays for blood & breast cancers, announced today that researchers from the University of Texas MD Anderson Cancer Center (MDACC, Houston, TX) will present the results of two studies on the Genomic Grade index (GGi) at the ASCO Annual Meeting, held in Chicago from May 30 to June 3, 2008. The data indicate that the Genomic Grade index predicts response to chemotherapy in breast cancer. A third study extends the pronostic utility of the GGi to inflammatory breast cancer.

The Genomic Grade index (GGi) is a 97-gene measure of tumor grade, a key prognostic indicator of breast cancer agressiveness closely related to cellular proliferation. Ipsogen is the exclusive worldwide licensee of the GGi technologies.

Two MD Anderson Cancer Center studies

In a preliminary study published in May 2008 in Breast Cancer Research (1) conducted on 133 patients, MDACC researchers had found that, among 852 genomic indexes describing biological pathways, the GGi was one of the most promising candidate for predicting response to chemotherapy.

In the first study to be presented (abstract 541, (2)), Dr. Symmans and colleagues from MDACC and Institut Bordet (Brussels, Belgium) validated the GGi as a predictive marker of chemotherapy response in 229 patients with HER2-normal breast cancer. All patients were treated with a current standard chemotherapy regimen, T/FAC (6 months of paclitaxel followed by 5-fluoruracil, doxorubicin, and cyclophosphamide) then by surgery. In such preoperative chemotherapy settings, treatment efficacy can be rapidly & precisely assessed by examining the resected tumor in a pathology laboratory.

This study concludes that high GGi is predictive for increased sensitivity to T/FAC chemotherapy in both ER- and ER+ patients. In addition, the GGi can be combined with ER and nodal status to p
'/>"/>

SOURCE Ipsogen
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)...   , July 2, 2015 BGI announced ... Hong Kong has been accredited by ... facility is the first clinical next-generation-sequencing laboratory to receive ... meeting the highest standard in clinical laboratory practices. Complementary to ... compliant laboratory process, and multiple ISO certifications, the CAP ...
(Date:7/1/2015)... , July 1, 2015 The ... group of state and regional professional rheumatology societies, ... of rheumatologists that explored perceptions of biosimilars and ... patients. Biosimilars are medicines that ... medicines. They are notably different from generic medications ...
(Date:7/1/2015)... , July 1, 2015 Eli Lilly and ... for the second quarter of 2015 on Thursday, July 23, ... day with the investment community and media to further detail ... begin at 9 a.m. EDT. Investors, media and the general ... through a link that will be posted on Lilly,s website ...
Breaking Medicine Technology:BGI Receives Accreditation from the College of American Pathologists (CAP) 2Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement 2
... CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH), developer of ... immunoassay segment of the In-Vitro Diagnostics market, announced the selection of ... a portable diagnostic platform designed to produce test results with central ... , , ...
... , June 21 ERT (Nasdaq: ... to the pharmaceutical, biotechnology and medical device industries, announced ... the Tufts Center for the Study of Drug Development, ... The industry-wide report measures the current and anticipated adoption ...
Cached Medicine Technology:CardioGenics Selects Clinical Test Sites for Its High Speed Portable Blood Analyzer 2CardioGenics Selects Clinical Test Sites for Its High Speed Portable Blood Analyzer 3CardioGenics Selects Clinical Test Sites for Its High Speed Portable Blood Analyzer 4ERT Announces New Report by TUFTS Identifying Growth in Adoption of Centralized ECG Services 2ERT Announces New Report by TUFTS Identifying Growth in Adoption of Centralized ECG Services 3ERT Announces New Report by TUFTS Identifying Growth in Adoption of Centralized ECG Services 4
(Date:7/2/2015)... ... ... In 2012, Patrick Achebe realized that the gift of poetry was fully in him, as ... first poem, and three years later he was publishing an entire book of poetry. He ... world. "I have always believed that the best way to lift yourself up, is in ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... of the SIGVARIS PERFORMANCE SOCKS. Since the socks were first introduced, they have ... Their significant popularity has inspired four new, fun shades including: blue, lime, pink ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... The ZAC ... the 2015 swim season with important lessons on how to stay water safe with ... Who Couldn’t, Wouldn’t Swim, authored by The ZAC Foundation co-founders, follows Zeke’s water safety ...
(Date:7/2/2015)... Dallas, TX (PRWEB) , ... ... ... “Negative pressure wound therapy (NPWT) - pipeline review 2015” provides comprehensive information ... stages of development. Complete report on negative pressure wound therapy (NPWT) with ...
(Date:7/2/2015)... ... July 02, 2015 , ... Facial plastic surgery ... precision. There is an art and science that goes into successful facial reconstruction ... the facial features and lives of more than 2,500 satisfied facelift and neck ...
Breaking Medicine News(10 mins):Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3
... Wednesday, May 7, Cedar,Point amusement park/resort will host the ... this special event will benefit the,Firelands Chapter of the ... at Cedar Point,s Challenge Park and will,be a four-person, ... shotgun start at 4:30 p.m. Teams of four can ...
... are highly effective at preventing acute respiratory illness and ... worse, according to research published in the April issue ... , A study of 87 patients with chronic obstructive ... health and death - found that having the annual ...
... CDI Program Utilizing the Expertise of Two Industry ... ... 15 Precyse Solutions, the leader in,driving peak performance within Health ... robust service,offerings and highly qualified team of HIM experts. Noted professionals ...
... Cynosure, Inc.,(Nasdaq: CYNO ), a leading ... aesthetic treatment systems, today announced that the company,will ... April 29, 2008,at 9:00 a.m. ET., On ... Davin and,Executive Vice President and Chief Financial Officer ...
... Benefits of Healthy, Wholesome Foods, JACKSONVILLE, Fla., April ... including those among children -- are at an all-time ... nutritional,information aimed at helping the youngest members of society ... resources like these,are few and far between., But ...
... they are to undergo screenings , , TUESDAY, April 15 ... women perceive their cancer risk may influence how likely ... cancer, says a University of California, San Francisco study. ... to 80, about breast, cervical and colon cancer. The ...
Cached Medicine News:Health News:Flu vaccines can reduce respiratory problems by up to 3/4 2Health News:Flu vaccines can reduce respiratory problems by up to 3/4 3Health News:Precyse Solutions Launches Clinical Documentation Improvement Program to Assist Hospitals in Accelerating Revenues 2Health News:Cynosure to Announce First-Quarter 2008 Financial Results on April 29 2Health News:Professor Woodpecker Makes Children's Nutrition Fun and Simple 2Health News:Professor Woodpecker Makes Children's Nutrition Fun and Simple 3Health News:Women's Awareness of Cancer Risk Linked to Race, Ethnicity 2
... is a high precision optical system for ... the anterior eye segment, based on a ... Placido Disk. , GALILEI combines the advantages ... accuracy curvature data, while Scheimpflug imaging is ...
... The C-VUE 55 Toric Multifocal ... also have presbyopia with all day ... visual acuity at every distance. This ... wide range of parameters with ADDs ...
... Nicknamed the SRS, this new and innovative stent ... the office right at the chair with just ... medical grade silicone and is available in three ... separately). At each end of the stent is ...
... Using flying spot technology the Technolas 217z ... for personalized vision correction, allows surgeons in ... to -7.00 Diopters and astigmatism up to ... combines both a 2mm and 1mm truncated ...
Medicine Products: